Depression affects approximately 9.5% of the U.S. adult population each year. It is also estimated that 17% of the U.S. population will experience a major depressive episode at some point in their lives. While the go-to treatment option for most depressed people is medicinal antidepressants, nearly 34% of those with depression do not respond at all to antidepressant medications. On top of that, nearly 10% can’t tolerate the side effects of these medications. This leaves nearly 50% of the population with depression with no medicinal answer to their depression and seeking alternative treatments and solutions. Multiple studies have proven that exercise is a viable solution to depression for many. In fact, studies have shown that moderate exercise such as walking for 30 minutes per day for 10 consecutive days was sufficient to yield a clinically relevant and statistically significant reduction in symptoms of depression. Research also shows that the benefits of exercise involvement can be long lasting. Depressed adults who took part in a fitness program displayed significantly greater improvements in depression, anxiety, and self-concept than those in a control group after 12 weeks of training. The exercise participants also maintained many of these gains through the 12-month follow-up period. In addition to exercise, Brainsway (www.brainsway.com), a leading company in developing and providing advanced technology solutions for the treatment of a variety of brain disorders has recently gained FDA approval for, and launched an all-new noninvasive treatment for depression called Deep TMS (Deep Transcranial Magnetic Stimulation) which can do for your brain what exercise does for your body.
Brainsway’s Deep TMS is a revolutionary treatment that stimulates the brain regions responsible for depression in a non-invasive way, using brief magnetic fields, at an amplitude similar to that used in magnetic resonance imaging (MRI) systems. It has been widely tested, participating in over 60 clinical trials worldwide. It is based on patents registered by the U.S. National Institutes of Health (NIH) and the company. Deep TMS works for the brain much in the same way as exercise does for the body. Like exercise stimulates muscles, prompting them to grow, change and improve, Deep TMS does to the brain. In those with depression, much of it is caused by certain regions of the brain being under-active, while other regions are over-active. Most notably the brain’s “reward system” is not functioning as it should. By focusing magnetic fields on particular parts of the brain that are under expressed in depressed patients, Deep TMS, has the ability to alter the way the brain functions and restores a balance to the depressed brain. Deep TMS can excite and restore proper function to under-active areas of the brain. It can also change focus and soothe other areas of the brain that may be over-active.
This comes as very exciting new to the millions of Americans who continue to live with depression that have found no help in traditional therapies and medications. What’s more, Deep TMS has now gained full FDA approval due to its high effectiveness in clinical trials, it is now covered by both Medicare and private insurers, making it readily accessible. Brainsway newly appointed CEO Dr. Guy Ezekiel noted that the success rate of the therapy is quite impressive: “We had the privilege of helping over 6,000 patients with Deep TMS and that number is growing on a daily basis. The safety and efficacy of our innovative technology has been proven in numerous clinical studies and published in peer-reviewed journals. We are committed to providing physicians with the tools they need to help their depressed patients find hope.”
Living with depression has been likened to walking through life carrying a 50lb weight at all times, making even seemingly easy tasks a monumental task for those affected. Many Americans continue to live with the burden of this debilitating disease. Brainsway’s new Deep TMS therapy will greatly improve the lives of millions in the years to come.